Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin W Teh

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
BMC Infectious Diseases|March 20, 2020
Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic settingOuli Xie, Monica A Slavin, Benjamin W Teh, et al.
Vaccine|February 2, 2025
"It's a risk-benefit analysis": Qualitative perspectives on barriers and enablers to post-treatment vaccination from adults affected by a haematological malignancy in AustraliaHolly Chung, Meinir Krishnasamy, Trish Joyce, et al.
British Journal of Haematology|June 25, 2015
Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapyBenjamin W Teh, Simon J Harrison, Leon J Worth, et al.
Blood Reviews|March 4, 2014
Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infectionBenjamin W Teh, Simon J Harrison, Marc Pellegrini, et al.
Vaccine|July 30, 2025
Recommendations for innovation in vaccination services for adults with haematological malignancies: an Australian cross-sectional survey studyHolly Chung, Meinir Krishnasamy, Trish Joyce, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 18, 2023
Predicting infections in patients with haematological malignancies treated with chimeric antigen receptor T-cell therapies: A systematic scoping review and narrative synthesisGemma Reynolds, Beatrice Sim, Mary Ann Anderson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 14, 2018
Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular TestingStarling A Sim, Vivian K Y Leung, David Ritchie, et al.
Medical Mycology|March 15, 2014
Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reactionBenjamin W Teh, Francesca A Azzato, Senthil M Lingaratnam, et al.
Internal Medicine Journal|December 22, 2021
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021Benjamin W Teh, Daniel K Yeoh, Gabrielle M Haeusler, et al.
Blood Advances|December 1, 2021
Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysisJoanne S K Teh, Julien Coussement, Zoe C F Neoh, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
BMC Infectious Diseases|March 20, 2020
Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic settingOuli Xie, Monica A Slavin, Benjamin W Teh, et al.
Vaccine|February 2, 2025
"It's a risk-benefit analysis": Qualitative perspectives on barriers and enablers to post-treatment vaccination from adults affected by a haematological malignancy in AustraliaHolly Chung, Meinir Krishnasamy, Trish Joyce, et al.
British Journal of Haematology|June 25, 2015
Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapyBenjamin W Teh, Simon J Harrison, Leon J Worth, et al.
Blood Reviews|March 4, 2014
Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infectionBenjamin W Teh, Simon J Harrison, Marc Pellegrini, et al.
Vaccine|July 30, 2025
Recommendations for innovation in vaccination services for adults with haematological malignancies: an Australian cross-sectional survey studyHolly Chung, Meinir Krishnasamy, Trish Joyce, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 18, 2023
Predicting infections in patients with haematological malignancies treated with chimeric antigen receptor T-cell therapies: A systematic scoping review and narrative synthesisGemma Reynolds, Beatrice Sim, Mary Ann Anderson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 14, 2018
Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular TestingStarling A Sim, Vivian K Y Leung, David Ritchie, et al.
Medical Mycology|March 15, 2014
Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reactionBenjamin W Teh, Francesca A Azzato, Senthil M Lingaratnam, et al.
Internal Medicine Journal|December 22, 2021
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021Benjamin W Teh, Daniel K Yeoh, Gabrielle M Haeusler, et al.
Blood Advances|December 1, 2021
Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysisJoanne S K Teh, Julien Coussement, Zoe C F Neoh, et al.
Pageof 7